article · Journal of the Nigerian Society of Physical Sciences
Nigeria faces challenges in the accurate diagnosis of respiratory diseases such as tuberculosis (TB), pneumonia, and COVID-19 because of limited radiology resources and stringent patient-privacy requirements. Deep learning models can provide strong diagnostic performance but often rely on centralised data, raising ethical and security concerns. This study presents an application-oriented privacy-preserving federated learning framework integrating Mobile Vision Transformer (MobileViT) for chest X-ray classification across simulated Nigerian healthcare environments. Using the Nigeria Chest X-ray Dataset (2,600 radiologist-labelled images across four classes), experiments were conducted in a simulated federated environment on a single compute instance with five clients as a proof of concept for multi-hospital collaboration. Differential privacy was implemented through differentially private stochastic gradient descent (DP-SGD), and performance was evaluated using accuracy, area under the curve (AUC), precision, recall, F1-score, and class-wise sensitivity. In this simulated setting, the differentially private federated learning (DP-FL) MobileViT model achieved test accuracy above 92% and a macro F1-score above 89% at moderate privacy budgets (varepsilon approx 5--6), while maintaining TB sensitivity above 85% and pneumonia sensitivity above 88%. These proof-of-concept results suggest that privacy-preserving federated learning could support reliable and ethical AI diagnostics in resource-limited Nigerian hospitals, pending real-world deployment validation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.46481/jnsps.2026.3466
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.